Sharda Cropchem profit and loss

Latest FY26
Revenue
₹5,268cr+21.9% on FY25
EBITDA
₹1,076cr+80.7% on FY25
Net profit
₹681cr+123.7% on FY25
EPS
₹75.47+123.7% on FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5,4795,2684,3203,1634,045
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
12310659.559.840.3
5,6025,3734,3793,2234,085
Expenses
2,1042,2291,7761,4841,552
1,4331,2461,3117991,616
−50.1−97.7−59.559.6−307
74.966.752.042.444.8
3.61.82.13.64.5
371325275267248
839747644495496
4,7754,5184,0013,1513,655
1,0781,076596283643
70775232115.7395
Profit
82785637871.9431
82785637871.9431
13014753.532.977.3
53.527.120.47.111.5
18317573.940.088.8
64468130431.9342
64468130431.9342
66.463.314.40.533.0
71074431932.5375
64468130431.9342
−0.00.10.00.00.0
Per share
₹71.34₹75.47₹33.74₹3.53₹37.90
₹71.34₹75.47₹33.74₹3.53₹37.90
Other comprehensive income — detail
66.463.314.4——
0.3−0.00.1−0.10.1
0.1−0.00.0——
———−0.00.0
66.263.314.30.733.0
71074431932.4375
−0.00.10.00.00.0
Per share — as-filed variants
₹71.34₹75.47₹33.74₹3.53₹37.90
₹71.34₹75.47₹33.74₹3.53₹37.90
Derived — gross profit (revenue − materials − purchases − Δ inventories)
1,9921,8901,2928211,184
36.4%35.9%29.9%25.9%29.3%
Adjusted (ex-exceptional items) — derived
82785637871.9431
64468130431.9342
₹71.34₹75.47₹33.74₹3.53₹37.90
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SHARDACROP₹642.00

Sharda Cropchem Ltd.

· Chemicals
AnnualQuarterly₹ CrorePeersUPLPIINDSTYRENIXREFEXSUDARSCHEMSUDEEPPHRMRCFRALLISMcap ₹5,792 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Revenue from Operations4,045.23,163.04,319.95,267.65,479.1
Other Income40.359.859.5105.5122.8
Total Income4,085.43,222.84,379.45,373.15,602.0
Expenses
+ Cost of Materials Consumed1,551.71,484.01,776.32,228.92,103.9
+ Purchases of Stock-in-Trade1,616.0798.71,311.21,246.11,432.9
+ Changes in Inventories-306.959.6-59.5-97.7-50.1
+ Employee Benefit Expense44.842.452.066.774.9
+ Finance Costs4.53.62.11.83.6
+ Depreciation & Amortisation248.1267.1274.7324.5370.9
+ Other Expenses496.5495.3644.2747.5839.3
Total Expenses3,654.73,150.94,001.04,517.64,775.4
EBITDA643.1282.9595.61,076.21,078.2
EBIT395.015.7320.9751.7707.3
Profit
PBT before Exceptional Items430.771.9378.3855.5826.6
Pretax Income430.771.9378.3855.5826.6
+ Current Tax77.332.953.5147.4129.5
+ Deferred Tax11.57.120.427.153.5
Tax Expense88.840.073.9174.5183.0
Net Income342.031.9304.4681.0643.6
+ Net Income — Continuing Ops342.031.9304.4681.0643.6
+ Other Comprehensive Income33.00.514.463.366.4
Total Comprehensive Income375.032.5318.8744.3710.0
Net Income to Common342.031.9304.4680.9643.6
Minority Interest0.00.00.00.1-0.0
Per Share
Basic EPS37.903.5333.7475.4771.34
Diluted EPS37.903.5333.7475.4771.34
Other Comprehensive Income — detail
+ Other Comprehensive Income——14.463.366.4
+ Items NOT to be Reclassified to P&L0.1-0.10.1-0.00.3
+ Tax on Items NOT to be Reclassified——0.0-0.00.1
+ Tax on Items NOT to be Reclassified — alt tag0.0-0.0———
+ Items to be Reclassified to P&L33.00.714.363.366.2
Comprehensive Income — Owners of Parent375.032.4318.7744.2710.0
Comprehensive Income — Non-controlling Interests0.00.00.00.1-0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations37.903.5333.7475.4771.34
Diluted EPS — Continuing Operations37.903.5333.7475.4771.34
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit1,184.4820.61,291.81,890.41,992.4
Gross Margin %29.2825.9429.9035.8936.36
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)430.771.9378.3855.5826.6
Net Income Adj (tax-effected)342.031.9304.4681.0643.6
EPS Adj37.903.5333.7475.4771.34
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.0010.00
Paid Up Equity Capital90.290.290.290.290.2
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.